Abstract: The novel sterilization process disclosed herein still relies on the sterilization action resulting from exposure of the liquids and inner surfaces of the medical article to appropriate temperatures for well-determined times, but the sterilization temperature shall be attained through generation of heat in the article itself and not through heat transfer from outside to inside. This shall be obtained through the generation of a medium to high frequency electromagnetic field, whose characteristics are precisely determined to reach the desired temperature in as little time as possible and to maintain it for the time required for safe sterilization of the article.

Abstract: Alloys for medical, surgical and microsurgical instruments are proposed which comprise 0.01% to 20% by weight of germanium, from 0-25% of shallow hydrogenic and/or non-hydrogenic acceptor dopants in terms of weight ratio in relation to germanium, from 0% up to 20% by weight of one or more of the following compounds such as platinum, gold, palladium, iridium, ruthenium, osmium, rhodium, niobium, tantalum, tungsten, aluminium, silicon, hafnium, yttrium, lanthanum, zirconium with the remainder, up to 100% by weight, constituted by silver and inevitable impurities, wherein instruments from these alloys possess properties such as no capacitive impedance in relation to the electrode-tissue interface; a Far Infrared Radiation (FIR) emitting capacity when energized by any form of energy; sulfurization, corrosion and oxidation resistant and have suitable hardness for their intended use; emit anions and may possess fractal surfaces.

Abstract: Alloys for medical, surgical and microsurgical instruments are proposed which comprise 0.01% to 20% by weight of germanium, from 0-25% of shallow hydrogenic and/or non-hydrogenic acceptor dopants in terms of weight ratio in relation to germanium, from 0% up to 20% by weight of one or more of the following compounds such as platinum, gold, palladium, iridium, ruthenium, osmium, rhodium, niobium, tantalum, tungsten, aluminium, silicon, hafnium, yttrium, lanthanum, zirconium with the remainder, up to 100% by weight, constituted by silver and inevitable impurities, wherein instruments from these alloys possess properties such as no capacitive impedance in relation to the electrode-tissue interface; a Far Infrared Radiation (FIR) emitting capacity when energized by any form of energy; sulfurization, corrosion and oxidation resistant and have suitable hardness for their intended use; emit anions and may possess fractal surfaces.

Abstract: The present invention relates to compositions comprising vitamins, such as L-ascorbic acid and its derivatives, sta-bilised with Olea Europea and/or ionene polymers. Particularly, the invention concerns stable compositions with high concentration of vitamins, for example L-ascorbic acid, to be advantageously employed in the medial and cosmetic field, for example for cosmetic and dermatological treatment of cute, mucous, and serosa.

Abstract: Alloys for medical, surgical and microsurgical instruments are proposed which comprise 0.01% to 20% by weight of germanium, from 0-25% of shallow hydrogenic and/or non-hydrogenic acceptor dopants in terms of weight ratio in relation to germanium, from 0% up to 20% by weight of one or more of the following compounds such as platinum, gold, palladium, iridium, ruthenium, osmium, rhodium, niobium, tantalum, tungsten, aluminium, silicon, hafnium, yttrium, lanthanum, zirconium with the remainder, up to 100% by weight, constituted by silver and inevitable impurities, wherein instruments from these alloys possess properties such as no capacitive impedance in relation to the electrode-tissue interface; a Far Infrared Radiation (FIR) emitting capacity when energized by any form of energy; sulfurization, corrosion and oxidation resistant and have suitable hardness for their intended use; emit anions and may possess fractal surfaces.

Abstract: To provide for controlled application of parenteral fluid to a patient, in which the fluid is supplied from a flexible bag which changes its volume as the fluid is withdrawn therefrom, a liquid flow control device (2) has a membrane which, intermittently closes off and opens flow communication from beneath a dripping tube (1a) and a cannula (8) applying the liquid to the patient, the side of the membrane remote from its control side being connected by a capillary tube (15) to the interior of the dripping tube to equalize the pressure changes occurring on both sides of the membrane as the liquid level in the supply vessel decreases. The flow rate is initially adjusted by lowering the level of the liquid stabilization device with respect to the level of the dripping chamber.

Abstract: To provide for constant and easily adjusted flow rate of liquids from a container (5), which may be a flexible bag, an indexed feeding chamber (1) is directly connected by gravity with the liquid container (5) and provided with a tubular passage (12) therethrough communicating with the outside, preferably through a filter at an end and with the chamber bottom at the other end. The bottom of the feeding chamber (1) is connected to a dripping tube (1A) positioned below, which in turn communicates with the inlet (21) of a device (2) for the microregulation and stabilization of the liquid flow rate. This device, essentially consists of a holder (44) with a cavity (51) therein and two tubular inlet (41) and outlet (47) passages connecting said cavity with the outside, and having a flexible membrane (43) removably covering the opening of the outlet passage within the cavity. Device (2) is height adjustably supported by a slider (31) on a scale (3) fixed to the stand (4 ) which supports the liquid container (5).